Streetbeat News

Stock Prices

AOS

AQWA

TBLU

A.O. Smith Corporation (NYSE:AOS) has lowered its FY24 guidance due to weak Q3 performance, primarily impacted by declining sales in China and North America's water heating segment. The company reported preliminary Q3 sales and EPS below estimates, leading to a significant drop in share price. Despite challenges, A.O. Smith expects improvement in North American water heater volumes in Q4, but anticipates continued softness in China. The company also announced a 6% dividend increase.

Portfolio Pulse from Lekha Gupta

October 11, 2024 | 4:30 pm

TSLA

Tesla's Robotaxi Day event was met with mixed reactions from analysts, with many expressing disappointment over the lack of clear business plans and updates on lower-cost production vehicles. Despite this, some analysts remain optimistic about Tesla's long-term prospects, particularly in AI and robotics. Tesla's stock has seen a decline following the event.

Portfolio Pulse from Chris Katje

October 11, 2024 | 4:26 pm

STHZF

StateHouse Holdings, a significant cannabis company, has filed for bankruptcy under Canada's Bankruptcy and Insolvency Act. This follows financial struggles and legal action by Pelorus Fund. Trading on the Canadian Securities Exchange has been halted, and the company may be delisted.

Portfolio Pulse from Juan Spínelli

October 11, 2024 | 4:25 pm

MNPR

Monopar Therapeutics shares rose following Rodman & Renshaw's initiation of coverage with a Buy rating and a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 4:25 pm

MS

XLF

Morgan Stanley shares rose by 2.6% following strong earnings from major financial institutions like JPMorgan Chase, Wells Fargo, and BlackRock. This positive sentiment boosted the Financial Select Sector SPDR Fund (XLF) as well. Morgan Stanley is expected to benefit from favorable market conditions, with its diversified revenue streams in investment banking and wealth management.

Portfolio Pulse from Henry Khederian

October 11, 2024 | 4:19 pm

CAPR

Capricor Therapeutics announced positive 3-year results from its HOPE-2 study for deramiocel, showing sustained cardiac and skeletal benefits in treating Duchenne muscular dystrophy. The study highlights improvements in cardiac function and a favorable safety profile, boosting CAPR stock by 8.05%.

Portfolio Pulse from Vandana Singh

October 11, 2024 | 4:18 pm

CAMP

Camp4 Therapeutics has begun trading on the stock market with shares opening at $11.16, following an IPO priced at $11 per share for 6.82 million shares.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 4:17 pm

MCD

McDonald's Inc. (NYSE:MCD) is trading at $304.19 with a slight increase of 0.05%. Over the past month, the stock rose by 2.58% and 21.71% over the past year. The company's P/E ratio is 26.62, lower than the industry average of 80.05, suggesting potential undervaluation or lower growth expectations compared to peers.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 4:15 pm

RDACU

The trading halt for an IPO security has been updated, and the security is now released for quotation as of 12:15 PM ET.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 4:15 pm